Start treating myopia today!


Optometrist and parent, Dr. Hannah Yecheskel calls MiSight® 1 day the “answer” to her 8-year old daughter’s rapidly progressing myopia.


Watch Video

MiSight® 1 day myopia control soft contact lenses are the first FDA-approved product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment
FDA-APPROVED*

MiSight® 1 day myopia control soft contact lenses are the first FDA-approved* product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment.†1

Learn More
HOW MISIGHT® 1 DAY WORKS
HOW MISIGHT® 1 DAY WORKS

Take a look at how ActivControl® Technology helps reduce the rate of myopia progression in children by 59% on average.†1

Watch Video
SUPPORTED BY A 7-YEAR STUDY
SUPPORTED BY A 7-YEAR STUDY

Evidence-based medicine: See the results of the 7-year international study demonstrating a strong safety profile.*†1-4

Learn More

Dual-benefit of
MiSight® 1 day:

CORRECTS BLURRY DISTANCE VISION icon

CORRECTS BLURRY DISTANCE VISION

Children wearing MiSight® 1 day achieved better than 20/20 vision across all visits over a 6-year period.*1,2

+

HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION icon

HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION

On average, age-appropriate children wearing MiSight® 1 day progressed less than -1.00D over 6 years.‡3

Learn about MiSight® 1 day for myopia control

Learn to prescribe MiSight ® 1 day and treat myopia in children through our 30-minute QuickStart program.

Watch Video

Myopia management is the standard of care

We can no longer let myopia get worse. Treat this disease seriously – your professional associations have spoken.5

DECEMBER 2020

American Academy of Ophthalmology logo
 
APRIL 2021

World Council of Optometry logo
JUNE 2021

American Academy of Pediatrics logo
Man and kid with baseball

Get Started Today!


Vera’s Story


Overcoming her family history of high myopia with MiSight® 1 day.


Watch Now

Make Children's SightYour Fight.

Indications and Important Safety Information.
Rx only.
Results may vary.

ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information.

* Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8- 12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

† Compared to a single vision 1 day lens over a 3-year period.

‡ Fitted at 8-12 years of age at initiation of treatment.

References:
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
2. Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6- year findings. Optom Vis Sci 2020;97(Eabstract): 200038.
3. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7-year findings. Optom Vis Sci 2021;98 (Eabstract): 210049.
4. Woods, J., Jones, D., Jones, L., Jones, S., Hunt, C., Chamberlain, P., & McNally, J. (2021). Ocular health of children wearing daily disposable contact lenses over a 6-year period. Contact Lens and Anterior Eye.
5. Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopiamanagement-byoptometrists.

MiSight® 1 day is a registered trademark of The Cooper Companies, Inc. and its subsidiaries.